| scholarly article | Q13442814 |
| P50 | author | Michael F. Holick | Q1394415 |
| Theresa Kim | Q42665557 | ||
| Daniel P Alford | Q42730471 | ||
| Jeffrey Samet | Q44867744 | ||
| P2093 | author name string | Alan Malabanan | |
| P2860 | cites work | The roles of adulthood behavioural factors and familial influences in bone density among men | Q57257408 |
| BMD Is Reduced in HIV-Infected Men Irrespective of Treatment | Q61457422 | ||
| Depression and bone mineral density in young adults: results from NHANES III | Q64133327 | ||
| Effects of chronic heroin abuse on bone and mineral metabolism | Q72880764 | ||
| Risk factors for osteoporosis in men | Q73037592 | ||
| Mortality after osteoporotic fractures | Q79238409 | ||
| Skeletal response to alcohol | Q34097189 | ||
| Linkage with primary medical care in a prospective cohort of adults with addictions in inpatient detoxification: room for improvement. | Q34336495 | ||
| Osteoporosis in men: suspect secondary disease first. | Q35100069 | ||
| Secondary screening for osteoporosis in patients admitted with minimal-trauma fracture to a major teaching hospital. | Q35600521 | ||
| New treatments for growing scourge of brittle bones | Q35634143 | ||
| Burden of medical illness in drug- and alcohol-dependent persons without primary care. | Q39675644 | ||
| Osteoporotic fracture: missed opportunity for intervention | Q40569670 | ||
| Diagnosis and treatment of osteoporosis in patients with vertebral compression fractures | Q40598235 | ||
| Predictors of follow-up health status in the Drug Abuse Treatment Outcome Study (DATOS). | Q40600680 | ||
| Expression of opioid receptors in osteoblast-like MG-63 cells, and effects of different opioid agonists on alkaline phosphatase and osteocalcin secretion by these cells. | Q40850250 | ||
| The enkephalinergic osteoblast | Q43070647 | ||
| Injury among detoxification patients: alcohol users' greater risk | Q43966413 | ||
| HIV infection and bone mineral density in middle-aged women | Q44256178 | ||
| Disability after clinical fracture in postmenopausal women with low bone density: the fracture intervention trial (FIT). | Q44309058 | ||
| Opioid osteoporosis | Q44344507 | ||
| Hypogonadism and osteoporosis in men. | Q44454850 | ||
| Alcohol and other factors affecting osteoporosis risk in women. | Q44521718 | ||
| Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men. | Q44645555 | ||
| Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: comparison with matched controls | Q44650303 | ||
| Osteoporosis in patients with schizophrenia | Q45206326 | ||
| Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. | Q45729264 | ||
| Menstrual cycle length during methadone maintenance | Q46512062 | ||
| Hormone secretion in methadone-dependent and abstinent patients. | Q54675851 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 258-262 | |
| P577 | publication date | 2006-07-21 | |
| P1433 | published in | Drug and Alcohol Dependence | Q5308875 |
| P1476 | title | Low bone density in patients receiving methadone maintenance treatment | |
| P478 | volume | 85 |
| Q64124348 | Alcohol Consumption and Bone Mineral Density in People with HIV and Substance Use Disorder: A Prospective Cohort Study |
| Q89987817 | Alcohol and Bone Turnover Markers among People Living with HIV and Substance Use Disorder |
| Q90684648 | An Investigation of the Risk Factors of Osteoporosis and the Correlation between Opium Consumption and Osteoporosis in Adults |
| Q46294271 | An intriguing association between dental and mental pathology in addicted and control subjects: a cross-sectional survey |
| Q37305173 | Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? A patient safety issue |
| Q51266217 | Bisphosphonate treatment may reduce osteoporosis risk in female cancer patients with morphine use: a population-based nested case-control study. |
| Q39029823 | Bone mineral density and its determinants in men with opioid dependence |
| Q52298931 | Bone mineral density in young women on methadone substitution. |
| Q35160980 | Changes in serum biochemical factors associated with opium addiction after addiction desertion |
| Q37412313 | Changes in the characteristics and levels of comorbidity among new patients into methadone maintenance treatment program in British Columbia during its expansion period from 1998-2006. |
| Q52297206 | Chronic immune stimulation as a contributing cause of chronic disease in opiate addiction including multi-system ageing |
| Q27692554 | Current and potential pharmacological treatment options for maintenance therapy in opioid-dependent individuals. |
| Q35943702 | Deficit of circulating stem--progenitor cells in opiate addiction: a pilot study |
| Q44339595 | Effects of Testosterone Replacement on Pain Catastrophizing and Sleep Quality in Men with Opioid-Induced Androgen Deficiency |
| Q47579387 | Effects of analgesics on bone mineral density: A longitudinal analysis of the prospective SWAN cohort with three-group matching weights |
| Q41564082 | Effects of testosterone replacement in men with opioid-induced androgen deficiency: a randomized controlled trial |
| Q44335561 | Effects of testosterone replacement on metabolic and inflammatory markers in men with opioid-induced androgen deficiency |
| Q48321734 | Effects of testosterone treatment on bone mineral density in hypogonadal men receiving intrathecal opioids |
| Q36300075 | Epidemiologic and molecular pathophysiology of chronic opioid dependence and the place of naltrexone extended-release formulations in its clinical management |
| Q33592228 | Evaluating the affect and reversibility of opioid-induced androgen deficiency in an orthopaedic animal fracture model |
| Q36092170 | Evidence of accelerated ageing in clinical drug addiction from immune, hepatic and metabolic biomarkers |
| Q21203516 | Experience of road and other trauma by the opiate dependent patient: a survey report |
| Q43100374 | Favorable mortality profile of naltrexone implants for opiate addiction |
| Q44277866 | High-sensitivity CRP in opiate addiction: relative and age-dependent elevations |
| Q38822085 | Hypogonadism: Its Prevalence and Diagnosis |
| Q33744915 | Impact of lifetime opioid exposure on arterial stiffness and vascular age: cross-sectional and longitudinal studies in men and women |
| Q34525271 | Improved parameters of metabolic glycaemic and immune function and arterial stiffness with naltrexone implant therapy |
| Q36022488 | Is opium addiction a risk factor for bone loss? |
| Q33627227 | Lifetime and recent alcohol use and bone mineral density in adults with HIV infection and substance dependence |
| Q37225383 | Lifetime opiate exposure as an independent and interactive cardiovascular risk factor in males: a cross-sectional clinical study |
| Q33763986 | Low vitamin d status of patients in methadone maintenance treatment |
| Q37733627 | Male Hypogonadism and Osteoporosis: The Effects, Clinical Consequences, and Treatment of Testosterone Deficiency in Bone Health |
| Q37982128 | Manifold implications of forgotten hyperglycemia in clinical opiate dependence |
| Q34034583 | Methadone: a substrate and mechanism-based inhibitor of CYP19 (aromatase). |
| Q37108575 | Opiate dependence as an independent and interactive risk factor for arterial stiffness and cardiovascular ageing - a longitudinal study in females |
| Q36681297 | Opioid maintenance: a comparative review of pharmacological strategies |
| Q37584104 | Opioid receptor agonists may favorably affect bone mechanical properties in rats with estrogen deficiency-induced osteoporosis |
| Q44339247 | Opioid use for noncancer pain and risk of fracture in adults: a nested case-control study using the general practice research database |
| Q90779687 | Opioid-induced endocrinopathies |
| Q43064811 | Opium and heroin alter biochemical parameters of human's serum |
| Q34192064 | Oral opioids for chronic non-cancer pain: higher prevalence of hypogonadism in men than in women. |
| Q28714245 | Potential contribution of aromatase inhibition to the effects of nicotine and related compounds on the brain |
| Q35230039 | Prevalence of low bone mineral density in a low-income inner-city population |
| Q35291766 | Prospective evaluation of bone mineral density among middle-aged HIV-infected and uninfected women: Association between methadone use and bone loss. |
| Q34116648 | Prospective study of bone mineral density changes in aging men with or at risk for HIV infection |
| Q36398092 | Psychosocial and treatment correlates of opiate free success in a clinical review of a naltrexone implant program |
| Q36730301 | Reduction in arterial stiffness and vascular age by naltrexone-induced interruption of opiate agonism: a cohort study |
| Q41144600 | Restoring the double disconnect: towards a conceptual reinstatement of opiate addiction as a high risk behaviour |
| Q37225210 | Rising inability to obtain needed health care among homeless persons in Birmingham, Alabama (1995-2005) |
| Q46486319 | Serum biochemical parameters following heroin withdrawal: an exploratory study. |
| Q38287553 | Sexual dysfunction in inflammatory bowel disease |
| Q35012377 | Smoking prevalence in addiction treatment: a review |
| Q36679731 | The association of opioid use with incident lower extremity fractures in spinal cord injury. |
| Q36570221 | The impact of substance abuse on osteoporosis screening and risk of osteoporosis in women with psychotic disorders |
| Q35284151 | The unsolved case of "bone-impairing analgesics": the endocrine effects of opioids on bone metabolism |
| Q35053957 | There is no age limit for methadone: a retrospective cohort study |
| Q92534027 | Using nominal group technique to identify barriers, facilitators, and preferences among patients seeking treatment for opioid use disorder: A needs assessment for decision making support |
| Q48248826 | What are the characteristics of vitamin D metabolism in opioid dependence? An exploratory longitudinal study in Australian primary care. |
Search more.